CN102584812A - Preparation method of tebipenem pivoxil impurities - Google Patents

Preparation method of tebipenem pivoxil impurities Download PDF

Info

Publication number
CN102584812A
CN102584812A CN2011103704366A CN201110370436A CN102584812A CN 102584812 A CN102584812 A CN 102584812A CN 2011103704366 A CN2011103704366 A CN 2011103704366A CN 201110370436 A CN201110370436 A CN 201110370436A CN 102584812 A CN102584812 A CN 102584812A
Authority
CN
China
Prior art keywords
typee
naoh
southern
training
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011103704366A
Other languages
Chinese (zh)
Other versions
CN102584812B (en
Inventor
李瑞远
刘立力
张广明
陈辉
陈齐阳
尹志媛
吕博雅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WANLE PHARMACEUTICAL CO Ltd SHENZHEN
Original Assignee
WANLE PHARMACEUTICAL CO Ltd SHENZHEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WANLE PHARMACEUTICAL CO Ltd SHENZHEN filed Critical WANLE PHARMACEUTICAL CO Ltd SHENZHEN
Priority to CN201110370436.6A priority Critical patent/CN102584812B/en
Publication of CN102584812A publication Critical patent/CN102584812A/en
Application granted granted Critical
Publication of CN102584812B publication Critical patent/CN102584812B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a preparation method of tebipenem pivoxil impurities. The preparation method has the advantages that the operation is simple and convenient, the condition that a dry solid product is obtained by using expensive freeze-drying equipment and column chromatography operated complexly to purify is avoided, the degree of purity is high and reaches above 97%, and reference substances of the impurities can be directly used in the quality research on tebipenem pivoxil crude drug.

Description

A kind of Typee is trained the preparation method of southern ester impurity
Technical field
The present invention relates to organic chemistry filed, further relate to the preparation method that a kind of Typee is trained southern ester impurity.
Background technology
A Typee training south volt ester (II) is a kind of novel oral carbapenems medicine by Wyeth Pharmaceuticals's research and development.This compound is that the reactive precursor Typee is trained the prodrug that southern C2 position carboxylic esterification forms.Typee is trained southern has a broad antifungal spectrum; To most of clinical strain separated (except that few part bacterial classification such as Enterococcus faecium (faecium) and Pseudomonas aeruginosa (Pseudomonas aeruginosa)); Typee training south all shows than penicillium mould series and the stronger bacterinertness of cephalo series; And compare with the carbapenem antibiotic of other injections, Typee training south also shows with degree or stronger antibacterial effect.Particularly show extremely strong antibacterial effect to the PRSP (penicillin resistant streptococcus pneumoniae), MRSP (anti-Oxacyclotetradecane,erythromycin deriv streptococcus pneumoniae) and the Haemophilus influenzae (hemophilus influenzae) that caused the childhood infection major cause in recent years.As the prodrug in Typee training south, a Typee training south volt ester has better absorption dynamics than Typee training south, and has satisfactory stability property.Its structural formula is:
Meeting decomposition, polymerization in acid or alkali environment produce some impurity thereby Typee is trained southern ester, show that according to the former related data that grinds company the impurity that possibly exist is as shown in the table:
Figure DEST_PATH_GSB00000748505100011
Table 1
When Typee being trained southern ester bulk drug and carries out quality approach, need to use the reference substance of these impurity that the impurity in the bulk drug is carried out the content monitoring, meet medicinal requirements to guarantee to prepare, can be used in the bulk drug of preparation safe and effective medicine preparation.
The Typee of formula II is trained southern ester beta-lactam nucleus open loop or hydrolysis of ester group is taken place under acidic conditions easily, and open loop produces impurity P2, and it is formula I compound that open loop while hydrolysis of ester group can produce impurity P9.
Summary of the invention
The invention provides a kind of Typee and train the preparation method of southern ester impurity, this method reaction conditions is gentle, and is easy and simple to handle, and the reaction times is short, and product purity is more than 97%.
A kind of method of training southern ester impurity suc as formula the Typee shown in (I) compound for preparing provided by the invention is characterized in that, comprises following steps:
1) reaction: Typee training south is added among the NaOH or HCl solution that concentration is 2N-5~10 ℃ of insulation reaction;
2) neutralization: adding concentration is HCl or NaOH solution adjusting pH to 4~6 of 2N;
3) solidify: add acetone and stir, leave standstill cooling, supernatant liquid inclines;
4) desalination: add ethanol or dissolve with methanol, cooling, suction filtration;
5) crystallization: add the isopropyl ether crystallization in the filtrating;
6) suction filtration, drying.
Figure BSA00000616647900031
Further optimize, the step 1) reaction times is 10~30 minutes; The weight/volume (g/ml) of Typee training south and NaOH or HCl solution is than being 1: 2~4 in the step 1), preferred 1: 2.5;
Step 2) pH value preferred 5.6 in;
Step 3) and 4) service temperature is-10~10 ℃, preferred-5~0 ℃;
The step 5) recrystallization temperature is-20~0 ℃, preferred-5~0 ℃;
The said drying means of step 6) is vacuum-drying.
Typee training used in the present invention south can be through any means preparation of the prior art, and purity is more than 99.5%.
Find in the experiment that NaOH that reaction is used or HCl solution are if the low excessively words of concentration react slower, and the volume of required acid of concentration low reaction or alkali is bigger; The water yield is more, add acetone make product and salt out required volume of organic solvent bigger, waste solvent and not easy to operate; If excessive concentration, temperature of reaction rises too high, wayward extent of reaction; Produce other impurity, confirm that therefore the concentration of employed NaOH or HCl solution is that 2N is the most suitable.And when regulating pH value, containing basic center and acid sites owing in formula (I) compound structure, peracid can cause forming hydrochloride; Cross alkali and can form sodium salt; Because the molecule quantitative change is big behind the salify, cause the last yield can be, and product be the mixture of title product formula (I) compound and salt thereof greater than theoretical yield; Through repeatedly the experiment and structural identification confirm that the scope of pH value is preferably between 4~6, most preferably the pH value 5.6.After step 3) adding acetone stirred and leaves standstill, lower floor was the mixture that comprises product and NaCl, and for tightly being attached to the sticky solid of container bottom, the upper strata is the mixed solvent of acetone and water, can directly incline to.
The invention provides a kind of preparation and train the method for southern ester impurity suc as formula the Typee shown in (I) compound; This method is easy and simple to handle; Avoided using the column chromatography purification of expensive freeze-drier and complex operation and having obtained the exsiccant solid phase prod; Product purity is high, reaches more than 97%, the impurity reference substance in the time of can directly being used as Typee and training southern ester bulk drug quality approach.
Embodiment below in conjunction with embodiment does further explain to the present invention.
Embodiment
Embodiment 1
Typee is trained southern 20g join precooling to-5~0 ℃ 2N NaOH solution 50ml ,-5~0 ℃ of insulation 30min.In reaction solution, be added dropwise to 2N HCl solution and transfer pH to 4.5, finishing adds acetone 800ml, is as cold as-5~0 ℃, leaves standstill the upper solution of inclining.Resistates adds 0 ℃ of ethanol 200ml dissolving, is chilled to-5 ℃, and suction filtration is removed insolubles, and filtrating is added dropwise to isopropyl ether 600ml, 0 ℃ of crystallization.Suction filtration, filter cake is transferred to room temperature vacuum-drying in the vacuum drying oven rapidly with the washing of 50ml isopropyl ether after draining, get white products 16.8g, and HPLC 98.2%, yield 95.5%.
Embodiment 2
Typee is trained among the 2N NaOH solution 50ml that southern 20g joins precooling to 0~5 ℃-5~0 ℃ of insulation 15min.In reaction solution, be added dropwise to 2N HCl solution and make PH5.6, finishing adds acetone 800ml, is chilled to-5~0 ℃, leaves standstill the upper solution of inclining.Resistates adds 0 ℃ of methyl alcohol 200ml dissolving, is chilled to-10 ℃, and suction filtration is removed insolubles, and filtrating is added dropwise to isopropyl ether 600ml ,-20 ℃ of crystallizatioies.Suction filtration, filter cake is transferred to room temperature vacuum-drying in the vacuum drying oven rapidly with the washing of 50ml isopropyl ether after draining, get white products 17.2g, and HPLC 97.5%, yield 97.8%.
Embodiment 3
Typee is trained southern 20g join precooling to-5~0 ℃ 2N HCl solution 50ml, 5~0 ℃ of insulation 30min.In reaction solution, be added dropwise to 2N NaOH solution and make PH5.6, finishing adds acetone 800ml, is chilled to-5~0 ℃, leaves standstill the upper solution of inclining.Resistates adds 0 ℃ of ethanol 200ml dissolving, is chilled to-5 ℃, and suction filtration is removed insolubles, and filtrating is added dropwise to isopropyl ether 600ml ,-5 ℃ of crystallizatioies.Suction filtration, filter cake is transferred to room temperature vacuum-drying in the vacuum drying oven rapidly with the washing of 50ml isopropyl ether after draining, get white products 15.7g, and HPLC 97.2%, yield 89.3%.
Embodiment 4
Typee is trained southern 20g join precooling to-5~0 ℃ 2N HCl solution 50ml, 0~10 ℃ of insulation 20min.In reaction solution, be added dropwise to 2N NaOH solution and make PH6, finishing adds acetone 800ml, is chilled to-5~0 ℃, leaves standstill the upper solution of inclining.Resistates adds 0 ℃ of ethanol 200ml dissolving, is chilled to-5 ℃, and suction filtration is removed insolubles, and filtrating is added dropwise to isopropyl ether 600ml ,-10 ℃ of crystallizatioies.Suction filtration, filter cake is transferred to room temperature vacuum-drying in the vacuum drying oven rapidly with the washing of 50ml isopropyl ether after draining, get white products 16.6g, and HPLC 97.6%, yield 94.4%.

Claims (9)

1. one kind prepares the method for training southern ester impurity suc as formula the Typee shown in (I) compound, it is characterized in that, comprises following steps:
1) reaction: Typee training south is added among the NaOH or HCl solution that concentration is 2N-5~10 ℃ of insulation reaction;
2) neutralization: adding concentration is HCl or NaOH solution adjusting pH to 4~6 of 2N;
3) solidify: add acetone and stir, leave standstill cooling, supernatant liquid inclines;
4) desalination: add ethanol or dissolve with methanol, cooling, suction filtration;
5) crystallization: add the isopropyl ether crystallization in the filtrating;
6) suction filtration, drying.
Figure FSA00000616647800011
2. method according to claim 1 is characterized in that the step 1) reaction times is 10~30 minutes.
3. method according to claim 1 is characterized in that the southern by weight/volume with NaOH or HCl solution of Typee training is 1: 2~5 in the step 1).
4. method according to claim 3 is characterized in that the southern by weight/volume with NaOH or HCl solution of Typee training is 1: 2.5 in the step 1).
5. method according to claim 1 is characterized in that step 2) in the pH value be 5.6.
6. method according to claim 1 is characterized in that step 3) and 4) service temperature be-10~10 ℃.
7. method according to claim 6 is characterized in that step 3) and 4) service temperature be-5~0 ℃.
8. method according to claim 1 is characterized in that the step 5) recrystallization temperature is-20~0 ℃.
9. method according to claim 1 is characterized in that the said drying means of step 6) is vacuum-drying.
CN201110370436.6A 2011-11-18 2011-11-18 Preparation method of tebipenem pivoxil impurities Expired - Fee Related CN102584812B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110370436.6A CN102584812B (en) 2011-11-18 2011-11-18 Preparation method of tebipenem pivoxil impurities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110370436.6A CN102584812B (en) 2011-11-18 2011-11-18 Preparation method of tebipenem pivoxil impurities

Publications (2)

Publication Number Publication Date
CN102584812A true CN102584812A (en) 2012-07-18
CN102584812B CN102584812B (en) 2014-03-12

Family

ID=46474133

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110370436.6A Expired - Fee Related CN102584812B (en) 2011-11-18 2011-11-18 Preparation method of tebipenem pivoxil impurities

Country Status (1)

Country Link
CN (1) CN102584812B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103709166A (en) * 2013-12-04 2014-04-09 深圳万乐药业有限公司 Synthetic method for Tebipenem Pivoxil polymer impurity
CN106699761A (en) * 2017-01-19 2017-05-24 成都倍特药业有限公司 Synthesis method for tebipenem pivoxil impurity P8

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997021712A1 (en) * 1995-12-08 1997-06-19 Lederle (Japan), Ltd. Carbapenem-3-carboxylic acid ester derivatives
EP0632039B1 (en) * 1993-07-01 2002-01-30 Wyeth Lederle Japan LTD. 2-[1-(1,3-Thiazolin-2-yl)azetidin-3-yl]thio-carbapenem derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0632039B1 (en) * 1993-07-01 2002-01-30 Wyeth Lederle Japan LTD. 2-[1-(1,3-Thiazolin-2-yl)azetidin-3-yl]thio-carbapenem derivatives
WO1997021712A1 (en) * 1995-12-08 1997-06-19 Lederle (Japan), Ltd. Carbapenem-3-carboxylic acid ester derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103709166A (en) * 2013-12-04 2014-04-09 深圳万乐药业有限公司 Synthetic method for Tebipenem Pivoxil polymer impurity
CN103709166B (en) * 2013-12-04 2015-09-23 深圳万乐药业有限公司 A kind of synthetic method of Tebipenem Pivoxil polymer impurity
CN106699761A (en) * 2017-01-19 2017-05-24 成都倍特药业有限公司 Synthesis method for tebipenem pivoxil impurity P8

Also Published As

Publication number Publication date
CN102584812B (en) 2014-03-12

Similar Documents

Publication Publication Date Title
CN102276611B (en) Method for purifying tebipenem by recrystallizing
CN107501268B (en) Preparation method of tebipenem pivoxil and intermediate thereof
CN102161667B (en) Sulbenicillin sodium and sulbenicillin sodium used for injection
CN103030651B (en) Method for preparing ceftazidime hydrochloride
CN102558181A (en) Preparation method of carbapenems
CN102584812A (en) Preparation method of tebipenem pivoxil impurities
CN104098548B (en) A kind of Delafloxacin process for purification
CN104530128A (en) Disodium tedizolid phosphate and preparation method thereof
CN101585845B (en) Preparation process of Mezlocillin
CN102351861A (en) Industrial preparation method of ertapenem
US8871927B2 (en) Method for purifying Ceftizoxime sodium
CN102391259A (en) Nifuratel compound and preparation method thereof
CN102746244B (en) Refining method of oteracil potassium
CN102304129B (en) Method for adapting to industrially producing tebipenem
CN104031043A (en) Novel synthesis method of moxifloxacin hydrochloride
CN101885727A (en) Method for preparing penipenem
CN102718781B (en) Preparation method of prulifloxacin
CN103127058A (en) Moxidectin preparation and preparing method thereof
CN101747352B (en) Preparation method for biapenem condensation compound crystal
CN108276398B (en) Preparation process of tebipenem pivoxil
CN102503940B (en) Method for preparing impurities from ring opening of Tebipenem ester
CN103030650A (en) Method for preparing cefotiam hexetil and method for preparing cefotiam hexetil dihydrochloride
CN104140416B (en) A kind of nolatrexed dihydrochloride crystal formation and preparation method and application
CN101723959B (en) Method for refining cefbuperazone
CN106316943A (en) Refining method of bedaquiline fumarate crystal form compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140312

Termination date: 20161118